Published in World J Gastroenterol on January 28, 2015
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. Ann Surg Oncol (2016) 0.75
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. J Am Coll Surg (2017) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol (1953) 25.08
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Hepatocellular carcinoma. Lancet (2003) 22.54
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst (1994) 7.91
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 6.01
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Surgery for small liver cancers. Semin Surg Oncol (1993) 3.00
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Recurrence of hepatocellular carcinoma after surgery. Br J Surg (1996) 2.27
[Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ]. Presse Med (1954) 2.18
Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology (1996) 1.64
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg (2005) 1.50
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology (1992) 1.35
Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg (2005) 1.11
Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg (2008) 1.07
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg (2006) 1.03
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Aliment Pharmacol Ther (2010) 1.03
Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer (2009) 1.02
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol (2009) 0.94
Adjuvant therapy after curative treatment for hepatocellular carcinoma. Oncology (2011) 0.93
Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol (2007) 0.92
Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg (2007) 0.89
Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience. Anticancer Res (2013) 0.83
Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg (2011) 0.77